{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T00:42:08Z","timestamp":1790728928196,"version":"4.1.0"},"reference-count":326,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T00:00:00Z","timestamp":1773792000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002081","name":"Irish Research Council","doi-asserted-by":"publisher","award":["GOIPD\/2024\/331"],"award-info":[{"award-number":["GOIPD\/2024\/331"]}],"id":[{"id":"10.13039\/501100002081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004162","name":"Meath Foundation","doi-asserted-by":"publisher","award":["RG105\/2018"],"award-info":[{"award-number":["RG105\/2018"]}],"id":[{"id":"10.13039\/501100004162","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100025294","name":"Research Ireland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100025294","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004318","name":"Microsoft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004318","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022542","name":"Breakthrough Cancer Research","doi-asserted-by":"publisher","award":["MBPhD-0122"],"award-info":[{"award-number":["MBPhD-0122"]}],"id":[{"id":"10.13039\/501100022542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.canlet.2026.218437","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T09:28:30Z","timestamp":1773826110000},"page":"218437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["The hallmarks of pancreatic cancer"],"prefix":"10.1016","volume":"650","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9107-6240","authenticated-orcid":false,"given":"Laura E.","family":"Kane","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hackett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G.","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2026.218437_bib1","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218437_bib2","doi-asserted-by":"crossref","first-page":"624","DOI":"10.3389\/fgene.2019.00624","article-title":"Survival analysis of multi-omics data identifies potential prognostic markers of pancreatic ductal adenocarcinoma","volume":"10","author":"Mishra","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14740\/wjon1166","article-title":"Epidemiology of pancreatic cancer: global trends, etiology and risk factors","volume":"10","author":"Rawla","year":"2019","journal-title":"World J. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib4","first-page":"7","article-title":"Cancer statistics","volume":"69","author":"Siegel","year":"2019","journal-title":"Ca - Cancer J. Clin."},{"key":"10.1016\/j.canlet.2026.218437_bib5","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1200\/JCO.21.02616","article-title":"Immunologic strategies in pancreatic cancer: making cold tumors hot","volume":"40","author":"Ullman","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/nm.2344","article-title":"Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy","volume":"17","author":"Collisson","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib7","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1038\/ng.3398","article-title":"Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma","volume":"47","author":"Moffitt","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","author":"Raphael","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.3390\/cancers10010017","article-title":"Advances in molecular profiling and categorisation of pancreatic adenocarcinoma and the implications for therapy","volume":"10","author":"Pihlak","year":"2018","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218437_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature11547","article-title":"Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes","volume":"491","author":"Biankin","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib11","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-020-0363-5","article-title":"The tumour microenvironment in pancreatic cancer\u2014clinical challenges and opportunities","volume":"17","author":"Ho","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1146\/annurev.pathmechdis.3.121806.154305","article-title":"Pancreatic cancer","volume":"3","author":"Maitra","year":"2008","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib13","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1038\/nature19823","article-title":"A renewed model of pancreatic cancer evolution based on genomic rearrangement patterns","volume":"538","author":"Notta","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib14","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/s41588-019-0566-9","article-title":"Transcription phenotypes of pancreatic cancer are driven by genomic events during tumor evolution","volume":"52","author":"Chan-Seng-Yue","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib15","doi-asserted-by":"crossref","first-page":"5577","DOI":"10.1016\/j.cell.2021.09.022","article-title":"Spatially confined sub-tumor microenvironments in pancreatic cancer","volume":"184","author":"Gr\u00fcnwald","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib16","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1038\/s41588-022-01134-8","article-title":"Single-nucleus and spatial transcriptome profiling of pancreatic cancer identifies multicellular dynamics associated with neoadjuvant treatment","volume":"54","author":"Hwang","year":"2022","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib17","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1038\/s43018-023-00628-6","article-title":"Persister cell phenotypes contribute to poor patient outcomes after neoadjuvant chemotherapy in PDAC","volume":"4","author":"Zhou","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1158\/2159-8290.CD-23-1541","article-title":"The evolutionary forest of pancreatic cancer","volume":"15","author":"Mullen","year":"2025","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1158\/1078-0432.CCR-19-1467","article-title":"Purity independent subtyping of tumors (PurIST), a clinically robust, single-sample classifier for tumor subtyping in pancreatic cancer","volume":"26","author":"Rashid","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib20","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1158\/1078-0432.CCR-14-1051","article-title":"Desmoplasia in primary tumors and metastatic lesions of pancreatic cancer","volume":"21","author":"Whatcott","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib21","series-title":"Pancreatic Stellate Cells in Health and Disease","author":"Mekapogu","year":"2020"},{"key":"10.1016\/j.canlet.2026.218437_bib22","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ags3.12225","article-title":"Role of the tumor microenvironment in pancreatic cancer","volume":"3","author":"Murakami","year":"2019","journal-title":"Ann. Gastroenterol. Surgery"},{"key":"10.1016\/j.canlet.2026.218437_bib23","doi-asserted-by":"crossref","first-page":"S32","DOI":"10.1016\/j.pan.2015.02.013","article-title":"Pancreatic cancer: the microenvironment needs attention too","volume":"15","author":"Apte","year":"2015","journal-title":"Pancreatology"},{"key":"10.1016\/j.canlet.2026.218437_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.canlet.2015.10.035","article-title":"Key role of pancreatic stellate cells in pancreatic cancer","volume":"381","author":"Pothula","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib25","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1053\/j.gastro.2005.03.025","article-title":"Cytokines and peroxisome proliferator-activated receptor \u03b3 ligand regulate phagocytosis by pancreatic stellate cells","volume":"128","author":"Shimizu","year":"2005","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib26","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1084\/jem.20162024","article-title":"Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer","volume":"214","author":"\u00d6hlund","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib27","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1097\/MOG.0000000000000196","article-title":"Pancreatic stellate cell: physiologic role, role in fibrosis and cancer","volume":"31","author":"Apte","year":"2015","journal-title":"Curr. Opin. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218437_bib28","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.2353\/ajpath.2010.090899","article-title":"Role of pancreatic stellate cells in pancreatic cancer metastasis","volume":"177","author":"Xu","year":"2010","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1053\/j.gastro.2012.11.037","article-title":"A starring role for stellate cells in the pancreatic cancer microenvironment","volume":"144","author":"Apte","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib30","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41575-020-0300-1","article-title":"Pancreatic cancer stroma: an update on therapeutic targeting strategies","volume":"17","author":"Hosein","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218437_bib31","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1158\/1535-7163.MCT-16-0834","article-title":"Inhibition of discoidin domain receptor 1 reduces collagen-mediated tumorigenicity in pancreatic ductal adenocarcinoma","volume":"16","author":"Aguilera","year":"2017","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218437_bib32","doi-asserted-by":"crossref","first-page":"3052","DOI":"10.1158\/1535-7163.MCT-10-0470","article-title":"Enzymatic depletion of tumor hyaluronan induces antitumor responses in preclinical animal models","volume":"9","author":"Thompson","year":"2010","journal-title":"Mol. Cancer Therapeut."},{"key":"10.1016\/j.canlet.2026.218437_bib33","doi-asserted-by":"crossref","first-page":"2766","DOI":"10.1158\/1078-0432.CCR-12-3654","article-title":"Phase I study of the Hedgehog pathway inhibitor IPI-926 in adult patients with solid tumors","volume":"19","author":"Jimeno","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.576399","article-title":"Stroma-targeting therapy in pancreatic cancer: one coin with two sides?","volume":"10","author":"Jiang","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib35","doi-asserted-by":"crossref","first-page":"487","DOI":"10.21037\/jgo.2016.03.03","article-title":"Targeting stromal microenvironment in pancreatic ductal adenocarcinoma: controversies and promises","volume":"7","author":"Mei","year":"2016","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1136\/gutjnl-2018-317424","article-title":"Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion","volume":"69","author":"Jiang","year":"2020","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib38","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.18632\/aging.100871","article-title":"Markers of cellular senescence. Telomere shortening as a marker of cellular senescence","volume":"8","author":"Bernadotte","year":"2016","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.canlet.2026.218437_bib40","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1080\/14728222.2019.1565658","article-title":"Pro-and anti-tumorigenic functions of the senescence-associated secretory phenotype","volume":"23","author":"Lau","year":"2019","journal-title":"Expert Opin. Ther. Targets"},{"key":"10.1016\/j.canlet.2026.218437_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer\u2014Then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000599","article-title":"A proteomic atlas of senescence-associated secretomes for aging biomarker development","volume":"18","author":"Basisty","year":"2020","journal-title":"PLoS Biol."},{"key":"10.1016\/j.canlet.2026.218437_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.3390\/ijms23010254","article-title":"Pancreatic cancer and cellular senescence: tumor microenvironment under the spotlight","volume":"23","author":"Cortesi","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib44","series-title":"Proceedings of the National Academy of Sciences","first-page":"12072","article-title":"Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging","volume":"vol. 98","author":"Krtolica","year":"2001"},{"key":"10.1016\/j.canlet.2026.218437_bib45","doi-asserted-by":"crossref","first-page":"4471","DOI":"10.1007\/s00018-017-2587-9","article-title":"Epithelial cell senescence: an adaptive response to pre-carcinogenic stresses?","volume":"74","author":"Abbadie","year":"2017","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib46","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1038\/onc.2011.350","article-title":"Cellular features of senescence during the evolution of human and murine ductal pancreatic cancer","volume":"31","author":"Caldwell","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218437_bib47","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s43556-023-00116-4","article-title":"Targeting chemoresistant senescent pancreatic cancer cells improves conventional treatment efficacy","volume":"4","author":"Jaber","year":"2023","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.canlet.2026.218437_bib48","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1053\/j.gastro.2018.12.044","article-title":"Fibroblasts in pancreatic ductal adenocarcinoma: biological mechanisms and therapeutic targets","volume":"156","author":"Whittle","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib49","doi-asserted-by":"crossref","first-page":"6162","DOI":"10.1038\/s41467-024-50441-7","article-title":"Senescent cancer-associated fibroblasts in pancreatic adenocarcinoma restrict CD8(+) T cell activation and limit responsiveness to immunotherapy in mice","volume":"15","author":"Assouline","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218437_bib50","article-title":"Revealing the role of cancer-associated fibroblast senescence in prognosis and immune landscape in pancreatic cancer","volume":"28","author":"Liu","year":"2025","journal-title":"iScience"},{"key":"10.1016\/j.canlet.2026.218437_bib51","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1158\/2159-8290.CD-23-0428","article-title":"Senescence defines a distinct subset of myofibroblasts that orchestrates immunosuppression in pancreatic cancer","volume":"14","author":"Belle","year":"2024","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib52","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib53","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib54","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/s41575-019-0245-4","article-title":"Role of oncogenic KRAS in the diagnosis, prognosis and treatment of pancreatic cancer","volume":"17","author":"Buscail","year":"2020","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218437_bib55","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature14169","article-title":"Whole genomes redefine the mutational landscape of pancreatic cancer","volume":"518","author":"Waddell","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib56","doi-asserted-by":"crossref","first-page":"6744","DOI":"10.1038\/ncomms7744","article-title":"Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets","volume":"6","author":"Witkiewicz","year":"2015","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218437_bib57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1038\/nature16965","article-title":"Genomic analyses identify molecular subtypes of pancreatic cancer","volume":"531","author":"Bailey","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib58","doi-asserted-by":"crossref","first-page":"2110","DOI":"10.1038\/sj.bjc.6601396","article-title":"Incidence, mechanism and prognostic value of activated AKT in pancreas cancer","volume":"89","author":"Schlieman","year":"2003","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib59","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/nrdp.2016.22","article-title":"Pancreatic cancer","volume":"2","author":"Kleeff","year":"2016","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.canlet.2026.218437_bib60","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.4161\/cbt.6.7.4328","article-title":"IL-6 stimulates Th2 type cytokine secretion and upregulates VEGF and NRP-1 expression in pancreatic cancer cells","volume":"6","author":"Feurino","year":"2007","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib61","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/srep41064","article-title":"Molecular, morphological and survival analysis of 177 resected pancreatic ductal adenocarcinomas (PDACs): identification of prognostic subtypes","volume":"7","author":"Schlitter","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218437_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0039-6060(98)70114-X","article-title":"Gene therapy for primary and metastatic pancreatic cancer with intraperitoneal retroviral vector bearing the wild-type p53 gene","volume":"124","author":"Hwang","year":"1998","journal-title":"Surgery"},{"key":"10.1016\/j.canlet.2026.218437_bib63","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/cgt.2015.33","article-title":"Expression of p53 synergistically augments caspases-mediated apoptosis induced by replication-competent adenoviruses in pancreatic carcinoma cells","volume":"22","author":"Takei","year":"2015","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib64","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13105-022-00875-8","article-title":"Tumour microenvironment and heterotypic interactions in pancreatic cancer","volume":"79","author":"Velasco","year":"2023","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.canlet.2026.218437_bib65","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1158\/0008-5472.CAN-12-2731","article-title":"Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses","volume":"73","author":"Mitchem","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib66","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.13115","article-title":"Role of the CCL2-CCR2 signalling axis in cancer: mechanisms and therapeutic targeting","volume":"54","author":"Xu","year":"2021","journal-title":"Cell Prolif."},{"key":"10.1016\/j.canlet.2026.218437_bib67","doi-asserted-by":"crossref","first-page":"7015","DOI":"10.1158\/1078-0432.CCR-11-0607","article-title":"Mast cells in tumor microenvironment promotes the in vivo growth of pancreatic ductal adenocarcinoma","volume":"17","author":"Chang","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib68","doi-asserted-by":"crossref","first-page":"3927","DOI":"10.1158\/0008-5472.CAN-12-4479","article-title":"Dynamic mast cell\u2013stromal cell interactions promote growth of pancreatic cancer","volume":"73","author":"Ma","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib69","doi-asserted-by":"crossref","first-page":"S51","DOI":"10.1111\/j.1440-1746.2009.06071.x","article-title":"New insights into alcoholic pancreatitis and pancreatic cancer","volume":"24","author":"Apte","year":"2009","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218437_bib70","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1172\/JCI71526","article-title":"Pancreatic cancer\u2013associated retinoblastoma 1 dysfunction enables TGF-\u03b2 to promote proliferation","volume":"124","author":"Gore","year":"2014","journal-title":"J. Clin. Investig."},{"key":"10.1016\/j.canlet.2026.218437_bib71","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib72","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/nrc3603","article-title":"The roles of TGF\u03b2 in the tumour microenvironment","volume":"13","author":"Pickup","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib73","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ccr.2007.01.017","article-title":"Kras(G12D) and Smad4\/Dpc4 haploinsufficiency cooperate to induce mucinous cystic neoplasms and invasive adenocarcinoma of the pancreas","volume":"11","author":"Izeradjene","year":"2007","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib74","doi-asserted-by":"crossref","first-page":"3573","DOI":"10.1242\/jcs.02554","article-title":"Non-smad TGF-beta signals","volume":"118","author":"Moustakas","year":"2005","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib75","doi-asserted-by":"crossref","first-page":"4271","DOI":"10.1038\/s41388-020-1289-1","article-title":"TGF-\u03b21 secreted by pancreatic stellate cells promotes stemness and tumourigenicity in pancreatic cancer cells through L1CAM downregulation","volume":"39","author":"Cave","year":"2020","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218437_bib76","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1158\/0008-5472.CAN-15-1293","article-title":"TGF\u03b2 signaling in the pancreatic tumor microenvironment promotes fibrosis and immune evasion to facilitate tumorigenesis","volume":"76","author":"Principe","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib77","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s10555-012-9375-7","article-title":"TGF-\u03b2 signalling and its role in cancer progression and metastasis","volume":"31","author":"Drabsch","year":"2012","journal-title":"Cancer Metastasis Rev."},{"key":"10.1016\/j.canlet.2026.218437_bib78","article-title":"Molecular markers of pancreatic cancer: a 10-Year retrospective review of molecular advances","volume":"14","author":"Jacks","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/j.canlet.2026.218437_bib79","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1136\/gutjnl-2011-300060","article-title":"Recruitment of histone deacetylases HDAC1 and HDAC2 by the transcriptional repressor ZEB1 downregulates E-cadherin expression in pancreatic cancer","volume":"61","author":"Aghdassi","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib80","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/ng.3753","article-title":"Epigenomic reprogramming during pancreatic cancer progression links anabolic glucose metabolism to distant metastasis","volume":"49","author":"McDonald","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib81","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/ng.3798","article-title":"Untangling the genetics from the epigenetics in pancreatic cancer metastasis","volume":"49","author":"Vakoc","year":"2017","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib82","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.1038\/s41388-019-0871-x","article-title":"Epigenetic reprogramming of primary pancreatic cancer cells counteracts their in vivo tumourigenicity","volume":"38","author":"Khoshchehreh","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2026.218437_bib83","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","article-title":"Metabolic regulation of gene expression by histone lactylation","volume":"574","author":"Zhang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib84","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/s12943-024-02008-9","article-title":"Positive feedback regulation between glycolysis and histone lactylation drives oncogenesis in pancreatic ductal adenocarcinoma","volume":"23","author":"Li","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-334361","article-title":"Histone lactylation-driven feedback loop modulates cholesterol-linked immunosuppression in pancreatic cancer","author":"Yang","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217117","article-title":"Histone lactylation dynamics: unlocking the triad of metabolism, epigenetics, and immune regulation in metastatic cascade of pancreatic cancer","volume":"598","author":"Wang","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib87","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1158\/0008-5472.CAN-24-3173","article-title":"Cancer-associated fibroblasts foster a high-lactate microenvironment to drive perineural invasion in pancreatic cancer","volume":"85","author":"Li","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib88","article-title":"Tumor cell-intrinsic SETD2 deficiency reprograms neutrophils to foster immune escape in pancreatic tumorigenesis","volume":"10","author":"Niu","year":"2023","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.canlet.2026.218437_bib89","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/j.ccell.2024.03.005","article-title":"Tumor cell-intrinsic epigenetic dysregulation shapes cancer-associated fibroblasts heterogeneity to metabolically support pancreatic cancer","volume":"42","author":"Niu","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib90","doi-asserted-by":"crossref","first-page":"E12343","DOI":"10.1073\/pnas.1812915116","article-title":"DeltaNp63-dependent super enhancers define molecular identity in pancreatic cancer by an interconnected transcription factor network","volume":"115","author":"Hamdan","year":"2018","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218437_bib91","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/s41419-024-06915-z","article-title":"DKK1-SE recruits AP1 to activate the target gene DKK1 thereby promoting pancreatic cancer progression","volume":"15","author":"Shao","year":"2024","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218437_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217284","article-title":"Exploring epigenetic dynamics unveils a super-enhancer-mediated NDRG1-\u03b2-catenin axis in modulating gemcitabine resistance in pancreatic cancer","volume":"605","author":"Wei","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib93","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.18632\/oncotarget.26704","article-title":"Super-enhancers: novel target for pancreatic ductal adenocarcinoma","volume":"10","author":"Ghosh","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218437_bib94","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/s41389-020-00285-9","article-title":"Triptolide targets super-enhancer networks in pancreatic cancer cells and cancer-associated fibroblasts","volume":"9","author":"Noel","year":"2020","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2026.218437_bib95","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s11427-017-9370-9","article-title":"Enhancer RNAs: a missing regulatory layer in gene transcription","volume":"62","author":"Mao","year":"2019","journal-title":"Sci. China Life Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib96","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1038\/s41588-023-01568-8","article-title":"Super-enhancer RNA m(6)A promotes local chromatin accessibility and oncogene transcription in pancreatic ductal adenocarcinoma","volume":"55","author":"Li","year":"2023","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.114176","article-title":"PRMT1 promotes epigenetic reprogramming associated with acquired chemoresistance in pancreatic cancer","volume":"43","author":"Nguyen","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.canlet.2026.218437_bib98","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13046-024-03268-5","article-title":"Targeting of the G9a, DNMT1 and UHRF1 epigenetic complex as an effective strategy against pancreatic ductal adenocarcinoma","volume":"44","author":"Oyon","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib99","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1038\/s41467-021-24798-y","article-title":"PRMT1-dependent regulation of RNA metabolism and DNA damage response sustains pancreatic ductal adenocarcinoma","volume":"12","author":"Giuliani","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.canlet.2026.218437_bib100","doi-asserted-by":"crossref","first-page":"3007","DOI":"10.1158\/0008-5472.CAN-12-4601","article-title":"Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner","volume":"73","author":"Mace","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib101","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/ijc.28736","article-title":"Tumor-associated macrophages exhibit pro- and anti-inflammatory properties by which they impact on pancreatic tumorigenesis","volume":"135","author":"Helm","year":"2014","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib102","doi-asserted-by":"crossref","first-page":"e211","DOI":"10.1016\/j.jss.2009.05.026","article-title":"Significance of M2-polarized tumor-associated macrophage in pancreatic cancer","volume":"167","author":"Kurahara","year":"2011","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.canlet.2026.218437_bib103","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1084\/jem.20100587","article-title":"HIF-1\u03b1 regulates function and differentiation of myeloid-derived suppressor cells in the tumor microenvironment","volume":"207","author":"Corzo","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib104","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/nri3175","article-title":"Coordinated regulation of myeloid cells by tumours","volume":"12","author":"Gabrilovich","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.canlet.2026.218437_bib105","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/j.cell.2016.07.046","article-title":"\u03b3\u03b4 T cells support pancreatic oncogenesis by restraining \u03b1\u03b2 T cell activation","volume":"166","author":"Daley","year":"2016","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib106","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1158\/2159-8290.CD-15-0827","article-title":"Bruton tyrosine kinase-dependent immune cell cross-talk drives pancreas cancer","volume":"6","author":"Gunderson","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib107","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1158\/2159-8290.CD-15-0843","article-title":"IL35-Producing B cells promote the development of pancreatic neoplasia","volume":"6","author":"Pylayeva-Gupta","year":"2016","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib108","article-title":"Role of immune cells in pancreatic cancer from bench to clinical application: an updated review","volume":"95","author":"Chang","year":"2016","journal-title":"Medicine (Baltim.)"},{"key":"10.1016\/j.canlet.2026.218437_bib109","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","article-title":"Dynamics of the immune reaction to pancreatic cancer from inception to invasion","volume":"67","author":"Clark","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib110","doi-asserted-by":"crossref","DOI":"10.4161\/onci.24891","article-title":"Pancreatic cancer-associated stellate cells: a viable target for reducing immunosuppression in the tumor microenvironment","volume":"2","author":"Mace","year":"2013","journal-title":"OncoImmunology"},{"key":"10.1016\/j.canlet.2026.218437_bib111","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene\u2013Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib112","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1136\/gut.2007.143941","article-title":"The chemokine receptor CXCR4 is expressed in pancreatic intraepithelial neoplasia","volume":"57","author":"Thomas","year":"2008","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib113","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/jso.21957","article-title":"Prognostic impact of CXCR4 and CXCR7 expression in pancreatic adenocarcinoma","volume":"104","author":"Gebauer","year":"2011","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib114","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1053\/j.gastro.2013.07.025","article-title":"Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma","volume":"145","author":"Ene-Obong","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib115","doi-asserted-by":"crossref","first-page":"3934","DOI":"10.1158\/1078-0432.CCR-19-0081","article-title":"Mobilization of CD8(+) T cells via CXCR4 blockade facilitates PD-1 checkpoint therapy in human pancreatic cancer","volume":"25","author":"Seo","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib116","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12943-021-01428-1","article-title":"Crosstalk between cancer-associated fibroblasts and immune cells in the tumor microenvironment: new findings and future perspectives","volume":"20","author":"Mao","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib117","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.7150\/ijbs.82317","article-title":"CXCL12-CXCR4\/CXCR7 axis in cancer: from mechanisms to clinical applications","volume":"19","author":"Yang","year":"2023","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib118","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1016\/j.ajpath.2010.11.058","article-title":"Overexpression of CXCL5 is associated with poor survival in patients with pancreatic cancer","volume":"178","author":"Li","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib119","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor cell-intrinsic factors underlie heterogeneity of immune cell infiltration and response to immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.canlet.2026.218437_bib120","doi-asserted-by":"crossref","first-page":"6","DOI":"10.21037\/tgh.2020.04.03","article-title":"Pancreatic cancer and immune checkpoint inhibitors\u2014still a long way to go","volume":"6","author":"Bian","year":"2021","journal-title":"Transl. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218437_bib121","unstructured":"Nagaraju, G. P., Malla, R. R., Basha, R. & Motofei, I. G. in Seminars in Cancer Biology. 616-621 (Elsevier)."},{"key":"10.1016\/j.canlet.2026.218437_bib122","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.canlet.2017.08.006","article-title":"PD-1\/PD-L1 and immunotherapy for pancreatic cancer","volume":"407","author":"Feng","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib123","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.hbpd.2018.03.007","article-title":"The clinicopathological and prognostic significance of PD-L1 expression in pancreatic cancer: a meta-analysis","volume":"17","author":"Gao","year":"2018","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.canlet.2026.218437_bib124","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1097\/PPO.0000000000000061","article-title":"Inducible expression of B7-H1 (PD-L1) and its selective role in tumor site immune modulation","volume":"20","author":"Sanmamed","year":"2014","journal-title":"Cancer J. (Sudbury, Mass.)"},{"key":"10.1016\/j.canlet.2026.218437_bib125","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cas.13874","article-title":"PD\u2010L1 expression enhancement by infiltrating macrophage\u2010derived tumor necrosis factor\u2010\u03b1 leads to poor pancreatic cancer prognosis","volume":"110","author":"Tsukamoto","year":"2019","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib126","first-page":"491","article-title":"The dark side of immunotherapy: pancreatic cancer","volume":"3","author":"Mucciolo","year":"2020","journal-title":"Cancer Drug Resist."},{"key":"10.1016\/j.canlet.2026.218437_bib127","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/s41698-024-00681-z","article-title":"Barriers and opportunities in pancreatic cancer immunotherapy","volume":"8","author":"Ju","year":"2024","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib128","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1002\/jso.24642","article-title":"Overcoming the resistance of pancreatic cancer to immune checkpoint inhibitors","volume":"116","author":"Skelton","year":"2017","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib129","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1158\/2326-6066.CIR-25-0575","article-title":"Nonredundant immune checkpoints direct therapeutic resistance to chemoimmunotherapy in pancreatic ductal adenocarcinoma","volume":"13","author":"Stone","year":"2025","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.canlet.2026.218437_bib130","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1158\/1055-9965.EPI-12-0671","article-title":"Telomere length and pancreatic cancer: a case\u2013control study","volume":"21","author":"Skinner","year":"2012","journal-title":"Cancer Epidemiol. Biomark. Prev."},{"key":"10.1016\/j.canlet.2026.218437_bib131","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-94711-6","article-title":"Human chromosome 3p21. 3 carries TERT transcriptional regulators in pancreatic cancer","volume":"11","author":"Yagyu","year":"2021","journal-title":"Sci. Rep."},{"key":"10.1016\/j.canlet.2026.218437_bib132","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0002-9440(10)64432-X","article-title":"Telomere shortening is nearly universal in pancreatic intraepithelial neoplasia","volume":"161","author":"Van Heek","year":"2002","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib133","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1002\/ijc.31928","article-title":"Genetic determinants of telomere length and risk of pancreatic cancer: a PANDoRA study","volume":"144","author":"Campa","year":"2019","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib134","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11605-007-0383-9","article-title":"Telomere shortening and telomerase expression during multistage carcinogenesis of intraductal papillary mucinous neoplasms of the pancreas","volume":"12","author":"Hashimoto","year":"2008","journal-title":"J. Gastrointest. Surg."},{"key":"10.1016\/j.canlet.2026.218437_bib135","article-title":"Understanding, diagnosing, and treating pancreatic cancer from the perspective of telomeres and telomerase","volume":"1\u201314","author":"Shou","year":"2024","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib136","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1245\/s10434-009-0333-8","article-title":"Positive regulation of human telomerase reverse transcriptase gene expression and telomerase activity by DNA methylation in pancreatic cancer","volume":"16","author":"Kumari","year":"2009","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib137","article-title":"Lactate dehydrogenase B is required for pancreatic cancer cell immortalization through activation of telomerase activity","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib138","doi-asserted-by":"crossref","first-page":"3145","DOI":"10.3390\/cancers13133145","article-title":"Telomerase and pluripotency factors jointly regulate stemness in pancreatic cancer stem cells","volume":"13","author":"Walter","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib139","doi-asserted-by":"crossref","first-page":"10","DOI":"10.4292\/wjgpt.v8.i1.10","article-title":"Pathogenic mechanisms of pancreatitis","volume":"8","author":"Manohar","year":"2017","journal-title":"World J. Gastrointest. Pharmacol. Therapeut"},{"key":"10.1016\/j.canlet.2026.218437_bib140","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1053\/j.gastro.2012.12.042","article-title":"Role of immune cells and immune-based therapies in pancreatitis and pancreatic ductal adenocarcinoma","volume":"144","author":"Zheng","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib141","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2025.1625114","article-title":"The role of inflammatory factors in the tumor microenvironment of pancreatic cancer","volume":"16","author":"Yuan","year":"2025","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218437_bib142","doi-asserted-by":"crossref","first-page":"488","DOI":"10.3390\/cells14070488","article-title":"The role of inflammation in cancer: mechanisms of tumor initiation, progression, and metastasis","volume":"14","author":"Nishida","year":"2025","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218437_bib143","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3892\/ijo.2015.3069","article-title":"TLR7 and TLR8 expression increases tumor cell proliferation and promotes chemoresistance in human pancreatic cancer","volume":"47","author":"Grimmig","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib144","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.3748\/wjg.v16.i23.2881","article-title":"Expression and significance of TLR4 and HIF-1alpha in pancreatic ductal adenocarcinoma","volume":"16","author":"Zhang","year":"2010","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.canlet.2026.218437_bib145","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41392-021-00658-5","article-title":"Inflammation and tumor progression: signaling pathways and targeted intervention","volume":"6","author":"Zhao","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib146","doi-asserted-by":"crossref","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs","volume":"9","author":"Chen","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218437_bib147","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12943-018-0858-1","article-title":"Tumor microenvironment participates in metastasis of pancreatic cancer","volume":"17","author":"Ren","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib148","article-title":"The immunoregulation effect of tumor microenvironment in pancreatic ductal adenocarcinoma","volume":"12","author":"Zhang","year":"2022","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib149","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.3390\/cancers17101599","article-title":"The role of the tumor microenvironment in pancreatic ductal adenocarcinoma: recent advancements and emerging therapeutic strategies","volume":"17","author":"Glapi\u0144ski","year":"2025","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib150","doi-asserted-by":"crossref","DOI":"10.1593\/neo.11332","article-title":"Interleukin 1\u03b1 sustains the expression of inflammatory factors in human pancreatic cancer microenvironment by targeting cancer-associated fibroblasts","volume":"13","author":"Tjomsland","year":"2011","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2026.218437_bib151","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1158\/0008-5472.CAN-19-2080","article-title":"Tumor cell-derived IL1\u03b2 promotes desmoplasia and immune suppression in pancreatic cancer","volume":"80","author":"Das","year":"2020","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib152","doi-asserted-by":"crossref","first-page":"81110","DOI":"10.18632\/oncotarget.13212","article-title":"Inhibiting tumor necrosis factor-alpha diminishes desmoplasia and inflammation to overcome chemoresistance in pancreatic ductal adenocarcinoma","volume":"7","author":"Zhao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218437_bib153","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155536","article-title":"Interleukin-6 participates in human pancreatic stellate cell activation and collagen I production via TGF-\u03b21\/Smad pathway","volume":"143","author":"Zheng","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.canlet.2026.218437_bib154","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1136\/gut.50.4.535","article-title":"Pancreatic stellate cells respond to inflammatory cytokines: potential role in chronic pancreatitis","volume":"50","author":"Mews","year":"2002","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib155","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2017.01.041","article-title":"Crosstalk between stromal cells and cancer cells in pancreatic cancer: new insights into stromal biology","volume":"392","author":"Zhan","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib156","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.canlet.2016.01.016","article-title":"Hypoxic stellate cells of pancreatic cancer stroma regulate extracellular matrix fiber organization and cancer cell motility","volume":"372","author":"Sada","year":"2016","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib157","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s12943-018-0815-z","article-title":"The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma","volume":"17","author":"Fu","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib158","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1158\/1078-0432.CCR-16-2319","article-title":"Current and emerging therapies in metastatic pancreatic cancer","volume":"23","author":"Manji","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib159","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3389\/fphys.2014.00141","article-title":"Role of pancreatic stellate cells in chemoresistance in pancreatic cancer","volume":"5","author":"McCarroll","year":"2014","journal-title":"Front. Physiol."},{"key":"10.1016\/j.canlet.2026.218437_bib160","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1097\/00006676-200207000-00008","article-title":"Cyclooxygenase-2 is overexpressed in chronic pancreatitis","volume":"25","author":"Schlosser","year":"2002","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2026.218437_bib161","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/1097-0142(20010115)91:2<333::AID-CNCR1006>3.0.CO;2-N","article-title":"Increased expression of cyclooxygenase-2 in human pancreatic neoplasms and potential for chemoprevention by cyclooxygenase inhibitors","volume":"91","author":"Kokawa","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib162","first-page":"987","article-title":"Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer","volume":"59","author":"Tucker","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib163","doi-asserted-by":"crossref","first-page":"10969","DOI":"10.18632\/oncotarget.2624","article-title":"Critical role of NF-\u03baB in pancreatic cancer","volume":"5","author":"Prabhu","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.canlet.2026.218437_bib164","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13184510","article-title":"NF-\u03baB and pancreatic cancer; chapter and verse","volume":"13","author":"Silke","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib165","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201301001","article-title":"Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-\u03baB and MMPs","volume":"202","author":"Liou","year":"2013","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.canlet.2026.218437_bib166","doi-asserted-by":"crossref","first-page":"20","DOI":"10.37349\/etat.2024.00202","article-title":"Role of STAT3 in pancreatic cancer","volume":"5","author":"Hamel","year":"2024","journal-title":"Explor Target Antitumor Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib167","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/ni.2060","article-title":"Inflammation meets cancer, with NF-\u03baB as the matchmaker","volume":"12","author":"Ben-Neriah","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.canlet.2026.218437_bib168","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a000141","article-title":"NF-kappaB as a critical link between inflammation and cancer","volume":"1","author":"Karin","year":"2009","journal-title":"Cold Spring Harbor Perspect. Biol."},{"key":"10.1016\/j.canlet.2026.218437_bib169","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1476-4598-12-86","article-title":"The complexity of NF-\u03baB signaling in inflammation and cancer","volume":"12","author":"Hoesel","year":"2013","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib170","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/nri.2017.142","article-title":"NF-\u03baB, inflammation, immunity and cancer: coming of age","volume":"18","author":"Taniguchi","year":"2018","journal-title":"Nat. Rev. Immunol."},{"issue":"12","key":"10.1016\/j.canlet.2026.218437_bib171","doi-asserted-by":"crossref","first-page":"3890","DOI":"10.3390\/ijms19123890","article-title":"Advancement of NF-\u03baB signaling pathway: a novel target in pancreatic cancer","volume":"19","author":"Pramanik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.canlet.2026.218437_bib172","first-page":"185","article-title":"NF-\u03baB, inflammation and pancreatic carcinogenesis: NF-\u03baB as a chemoprevention target","volume":"29","author":"Zhang","year":"2006","journal-title":"International journal of oncology"},{"key":"10.1016\/j.canlet.2026.218437_bib173","article-title":"NF-\u03baB\/Rel transcription factors in pancreatic cancer: focusing on RelA, c-Rel, and RelB","volume":"11(7) p.937","author":"Kabacaoglu","year":"2019","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib174","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1001\/jama.2021.13027","article-title":"Pancreatic cancer: a review","volume":"326","author":"Park","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.canlet.2026.218437_bib175","doi-asserted-by":"crossref","first-page":"5020","DOI":"10.1158\/0008-5472.CAN-11-0908","article-title":"STAT3 plays a critical role in KRAS-induced pancreatic tumorigenesis","volume":"71","author":"Corcoran","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib176","doi-asserted-by":"crossref","first-page":"4852","DOI":"10.1158\/0008-5472.CAN-15-0896","article-title":"IL17 functions through the novel REG3\u03b2-JAK2-STAT3 inflammatory pathway to promote the transition from chronic pancreatitis to pancreatic cancer","volume":"75","author":"Loncle","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib177","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.ccr.2014.03.014","article-title":"Oncogenic Kras activates a hematopoietic-to-epithelial IL-17 signaling axis in preinvasive pancreatic neoplasia","volume":"25","author":"McAllister","year":"2014","journal-title":"Cancer Cell"},{"issue":"12","key":"10.1016\/j.canlet.2026.218437_bib178","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1016\/j.tim.2022.08.004","article-title":"Polymorphic microbes: a new emerging hallmark of cancer","volume":"30","author":"Lythgoe","year":"2022","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.canlet.2026.218437_bib179","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1126\/science.aay9189","article-title":"The human tumor microbiome is composed of tumor type\u2013specific intracellular bacteria","volume":"368","author":"Nejman","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218437_bib180","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1136\/gutjnl-2018-317458","article-title":"Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer","volume":"68","author":"Gaiser","year":"2019","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib181","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1158\/1055-9965.EPI-18-0542","article-title":"The microbiomes of pancreatic and duodenum tissue overlap and are highly subject specific but differ between pancreatic cancer and noncancer subjects","volume":"28","author":"Del Castillo","year":"2019","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.canlet.2026.218437_bib182","doi-asserted-by":"crossref","first-page":"e196","DOI":"10.1016\/j.cgh.2020.11.006","article-title":"Alterations in the duodenal fluid microbiome of patients with pancreatic cancer","volume":"20","author":"Kohi","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.canlet.2026.218437_bib183","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2159-8290.CD-17-1134","article-title":"The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression","volume":"8","author":"Pushalkar","year":"2018","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib184","article-title":"Intratumor microbiome analysis identifies positive association between megasphaera and survival of Chinese patients with pancreatic ductal adenocarcinomas","volume":"13","author":"Huang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218437_bib185","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/carcin\/bgy073","article-title":"Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models","volume":"39","author":"Thomas","year":"2018","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.canlet.2026.218437_bib186","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41392-023-01406-7","article-title":"Role of the gut microbiota in anticancer therapy: from molecular mechanisms to clinical applications","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib187","doi-asserted-by":"crossref","first-page":"eabn4948","DOI":"10.1126\/scisignal.abn4948","article-title":"Fusobacterium nucleatum induces proliferation and migration in pancreatic cancer cells through host autocrine and paracrine signaling","volume":"15","author":"Udayasuryan","year":"2022","journal-title":"Sci. Signal."},{"key":"10.1016\/j.canlet.2026.218437_bib188","doi-asserted-by":"crossref","first-page":"3666","DOI":"10.1111\/cas.15901","article-title":"Intratumor Fusobacterium nucleatum promotes the progression of pancreatic cancer via the CXCL1-CXCR2 axis","volume":"114","author":"Hayashi","year":"2023","journal-title":"Cancer Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib189","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/gutjnl-2016-312580","article-title":"Human oral microbiome and prospective risk for pancreatic cancer: a population-based nested case-control study","volume":"67","author":"Fan","year":"2018","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib190","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2025.1619323","article-title":"Changes in intestinal microbiota in patients with pancreatic cancer: a systematic review and meta-analysis","volume":"16","author":"Liang","year":"2025","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.canlet.2026.218437_bib191","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1097\/JS9.0000000000001724","article-title":"Gut microbiome changes associated with chronic pancreatitis and pancreatic cancer: a systematic review and meta-analysis","volume":"110","author":"Hong","year":"2024","journal-title":"Int. J. Surg."},{"key":"10.1016\/j.canlet.2026.218437_bib192","doi-asserted-by":"crossref","first-page":"8635","DOI":"10.1245\/s10434-023-14366-7","article-title":"Does oral microbiota have a close relationship with pancreatic cancer? A systematic review and meta-analysis","volume":"30","author":"Ma","year":"2023","journal-title":"Ann. Surg Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib193","article-title":"Oral-gut microbiome axis in gastrointestinal disease and cancer","volume":"13","author":"Park","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib194","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1093\/annonc\/mdx019","article-title":"Periodontal disease, edentulism, and pancreatic cancer: a meta-analysis","volume":"28","author":"Maisonneuve","year":"2017","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib195","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1136\/gutjnl-2011-300784","article-title":"Variations of oral microbiota are associated with pancreatic diseases including pancreatic cancer","volume":"61","author":"Farrell","year":"2012","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib196","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1038\/s41416-022-02018-8","article-title":"Poor dental health and risk of pancreatic cancer: a nationwide registry-based cohort study in Sweden, 2009-2016","volume":"127","author":"Yu","year":"2022","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib197","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1136\/gutjnl-2012-303006","article-title":"Plasma antibodies to oral bacteria and risk of pancreatic cancer in a large European prospective cohort study","volume":"62","author":"Michaud","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib198","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1001\/jamaoncol.2025.3377","article-title":"Oral bacterial and fungal microbiome and subsequent risk for pancreatic cancer","volume":"11","author":"Meng","year":"2025","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib199","doi-asserted-by":"crossref","DOI":"10.1002\/jgh3.70105","article-title":"Causal exposures in pancreatic cancer incidence: insights from mendelian randomization studies","volume":"9","author":"Mohamadkhani","year":"2025","journal-title":"JGH Open"},{"key":"10.1016\/j.canlet.2026.218437_bib200","article-title":"Investigating the causal relationship between gut microbiota and gastroenteropancreatic neuroendocrine neoplasms: a bidirectional Mendelian randomization study","volume":"15","author":"Zhang","year":"2024","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.canlet.2026.218437_bib201","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12082331","article-title":"Intracellular Porphyromonas gingivalis promotes the tumorigenic behavior of pancreatic carcinoma cells","volume":"12","author":"Gnanasekaran","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib202","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12123522","article-title":"Lactobacillus attenuate the progression of pancreatic cancer promoted by Porphyromonas gingivalis in K-ras(G12D) transgenic mice","volume":"12","author":"Chen","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib203","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2022.2073785","article-title":"Periodontitis pathogen Porphyromonas gingivalis promotes pancreatic tumorigenesis via neutrophil elastase from tumor-associated neutrophils","volume":"14","author":"Tan","year":"2022","journal-title":"Gut Microbes"},{"key":"10.1016\/j.canlet.2026.218437_bib204","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/PPO.0000000000000045","article-title":"Pancreatic cancer, inflammation, and microbiome","volume":"20","author":"Zambirinis","year":"2014","journal-title":"Cancer J."},{"key":"10.1016\/j.canlet.2026.218437_bib205","article-title":"Bidirectional and dynamic interaction between the microbiota and therapeutic resistance in pancreatic cancer","volume":"1875","author":"Dong","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218437_bib206","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12943-023-01813-y","article-title":"Molecular and metabolic regulation of immunosuppression in metastatic pancreatic ductal adenocarcinoma","volume":"22","author":"Gautam","year":"2023","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib207","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.bbamcr.2005.07.003","article-title":"Sodium butyrate sensitises human pancreatic cancer cells to both the intrinsic and the extrinsic apoptotic pathways","volume":"1745","author":"Natoni","year":"2005","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.canlet.2026.218437_bib208","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.580","article-title":"Tuning gut microbiota through a probiotic blend in gemcitabine-treated pancreatic cancer xenografted mice","volume":"11","author":"Panebianco","year":"2021","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113163","article-title":"Butyrate, a postbiotic of intestinal bacteria, affects pancreatic cancer and gemcitabine response in in vitro and in vivo models","volume":"151","author":"Panebianco","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.canlet.2026.218437_bib210","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41586-023-05728-y","article-title":"Microbiota-derived 3-IAA influences chemotherapy efficacy in pancreatic cancer","volume":"615","author":"Tintelnot","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib211","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<347::AID-PATH848>3.0.CO;2-J","article-title":"Imbalance of expression of matrix metalloproteinases (MMPs) and tissue inhibitors of the matrix metalloproteinases (TIMPs) in human pancreatic carcinoma","volume":"182","author":"Bramhall","year":"1997","journal-title":"J. Pathol.: J. Pathol. Soc. Great Britain Ireland"},{"key":"10.1016\/j.canlet.2026.218437_bib212","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/(SICI)1096-9896(199911)189:3<300::AID-PATH456>3.0.CO;2-C","article-title":"Matrix metalloproteinases in tumour invasion and metastasis","volume":"189","author":"Curran","year":"1999","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib213","doi-asserted-by":"crossref","first-page":"2832","DOI":"10.1158\/1078-0432.CCR-1157-03","article-title":"Comprehensive analysis of matrix metalloproteinase and tissue inhibitor expression in pancreatic cancer: increased expression of matrix metalloproteinase-7 predicts poor survival","volume":"10","author":"Jones","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib214","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/jso.10106","article-title":"Comparison of matrix metalloproteinase expression between primary tumors with or without liver metastasis in pancreatic and colorectal carcinomas","volume":"80","author":"Matsuyama","year":"2002","journal-title":"J. Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib215","first-page":"285","volume":"vol. 21","author":"Okada","year":"2004"},{"key":"10.1016\/j.canlet.2026.218437_bib216","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1242\/jcs.03347","article-title":"Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay","volume":"120","author":"Schneiderhan","year":"2007","journal-title":"J. Cell Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib217","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1136\/gut.52.2.275","article-title":"Rat pancreatic stellate cells secrete matrix metalloproteinases: implications for extracellular matrix turnover","volume":"52","author":"Phillips","year":"2003","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib218","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1002\/ijc.2910620409","article-title":"Expression and in\u2010situ localization of genes coding for extracellular matrix proteins and extracellular matrix degrading proteases in pancreatic cancer","volume":"62","author":"Gress","year":"1995","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib219","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1097-0215(20000101)85:1<14::AID-IJC3>3.0.CO;2-O","article-title":"Role of MT\u2010MMPs and MMP\u20102 in pancreatic cancer progression","volume":"85","author":"Ellenrieder","year":"2000","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib220","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/bs.pmbts.2017.03.004","article-title":"The roles of matrix metalloproteinases in pancreatic cancer","volume":"148","author":"Knapinska","year":"2017","journal-title":"Progr. Mol. Biol. Translati. Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib221","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1002\/cam4.719","article-title":"Transcriptome profiling reveals novel gene expression signatures and regulating transcription factors of TGF \u03b2\u2010induced epithelial\u2010to\u2010mesenchymal transition","volume":"5","author":"Du","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.canlet.2026.218437_bib222","doi-asserted-by":"crossref","first-page":"4125","DOI":"10.1158\/1078-0432.CCR-0578-03","article-title":"N-cadherin expression and epithelial-mesenchymal transition in pancreatic carcinoma","volume":"10","author":"Nakajima","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib223","doi-asserted-by":"crossref","first-page":"4769","DOI":"10.1158\/1078-0432.CCR-06-2926","article-title":"Epithelial to mesenchymal transition: expression of the regulators snail, slug, and twist in pancreatic cancer","volume":"13","author":"Hotz","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib224","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1158\/0008-5472.CAN-06-2030","article-title":"Identification of pancreatic cancer stem cells","volume":"67","author":"Li","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib225","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2007.06.002","article-title":"Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer","volume":"1","author":"Hermann","year":"2007","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib226","article-title":"Prognostic value of cancer stem cell marker CD133 expression in pancreatic ductal adenocarcinoma (PDAC): a systematic review and meta-analysis","volume":"8","author":"Li","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib227","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10456-018-9645-2","article-title":"Angiogenesis in pancreatic cancer: current research status and clinical implications","volume":"22","author":"Li","year":"2019","journal-title":"Angiogenesis"},{"key":"10.1016\/j.canlet.2026.218437_bib228","doi-asserted-by":"crossref","first-page":"381","DOI":"10.3390\/cancers11030381","article-title":"Angiogenesis in pancreatic cancer: pre-clinical and clinical studies","volume":"11","author":"Annese","year":"2019","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218437_bib229","doi-asserted-by":"crossref","first-page":"G709","DOI":"10.1152\/ajpgi.90356.2008","article-title":"Hypoxia stimulates pancreatic stellate cells to induce fibrosis and angiogenesis in pancreatic cancer","volume":"295","author":"Masamune","year":"2008","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"10.1016\/j.canlet.2026.218437_bib230","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1002\/path.4506","article-title":"Identification of novel vascular projections with cellular trafficking abilities on the microvasculature of pancreatic ductal adenocarcinoma","volume":"236","author":"Saiyin","year":"2015","journal-title":"J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib231","doi-asserted-by":"crossref","DOI":"10.1096\/fj.201900786R","article-title":"Endothelial cell-specific redox gene modulation inhibits angiogenesis but promotes B16F0 tumor growth in mice","volume":"33","author":"Yura","year":"2019","journal-title":"FASEB J."},{"key":"10.1016\/j.canlet.2026.218437_bib232","article-title":"Mechanisms of angiogenesis in tumour","volume":"14","author":"Zhang","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib233","doi-asserted-by":"crossref","first-page":"11571","DOI":"10.1007\/s00432-023-05015-3","article-title":"LncRNAs associated with vascular mimicry establish a novel molecular subtype and prognostic model for pancreatic cancer","volume":"149","author":"Li","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"9","key":"10.1016\/j.canlet.2026.218437_bib234","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1136\/gutjnl-2024-333638","article-title":"Endothelial-like cancer-associated fibroblasts facilitate pancreatic cancer metastasis via vasculogenic mimicry and paracrine signalling","volume":"74","author":"Sun","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.canlet.2026.218437_bib235","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0279001","article-title":"Notch signaling regulates vasculogenic mimicry and promotes cell morphogenesis and the epithelial-to-mesenchymal transition in pancreatic ductal adenocarcinoma","volume":"17","author":"Benjakul","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/j.canlet.2026.218437_bib236","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-020-01288-1","article-title":"Mechanisms of vasculogenic mimicry in hypoxic tumor microenvironments","volume":"20","author":"Wei","year":"2021","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib237","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2025.156437","article-title":"Rg3 inhibits hypoxia-induced tumor exosomes from boosting pancreatic cancer vasculogenic mimicry through the HIF-1\u03b1\/LARS1\/mTOR axis","volume":"139","author":"Zhao","year":"2025","journal-title":"Phytomedicine"},{"key":"10.1016\/j.canlet.2026.218437_bib238","doi-asserted-by":"crossref","DOI":"10.1002\/adbi.202200192","article-title":"Cancer neuroscience: evidence for a new hallmark of cancer","volume":"6","author":"Amit","year":"2022","journal-title":"Adv. Biol"},{"key":"10.1016\/j.canlet.2026.218437_bib239","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.ccell.2023.02.012","article-title":"Cancer hallmarks intersect with neuroscience in the tumor microenvironment","volume":"41","author":"Hanahan","year":"2023","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib240","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1038\/s41586-023-05968-y","article-title":"The neuroscience of cancer","volume":"618","author":"Mancusi","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib241","doi-asserted-by":"crossref","first-page":"4594","DOI":"10.3390\/cancers13184594","article-title":"Perineural invasion and associated pain transmission in pancreatic cancer","volume":"13","author":"Wang","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218437_bib242","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1097\/SLA.0000000000000968","article-title":"The impact of neural invasion severity in gastrointestinal malignancies: a clinicopathological study","volume":"260","author":"Liebl","year":"2014","journal-title":"Ann. Surg."},{"key":"10.1016\/j.canlet.2026.218437_bib243","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1158\/2159-8290.CD-21-1690","article-title":"Reprogrammed schwann cells organize into dynamic tracks that promote pancreatic cancer invasion","volume":"12","author":"Deborde","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib244","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.suronc.2017.01.007","article-title":"The influence of neural invasion on survival and tumor recurrence in pancreatic ductal adenocarcinoma\u2013a systematic review and meta-analysis","volume":"26","author":"Schorn","year":"2017","journal-title":"Surg. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib245","article-title":"Hallmarks of perineural invasion in pancreatic ductal adenocarcinoma: new biological dimensions","volume":"14","author":"Sun","year":"2024","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib246","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s12264-023-01082-1","article-title":"Crosstalk between peripheral innervation and pancreatic ductal adenocarcinoma","volume":"39","author":"Ni","year":"2023","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.canlet.2026.218437_bib247","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1080\/08977190903132273","article-title":"Transforming growth factor-\u03b2 induces nerve growth factor expression in pancreatic stellate cells by activation of the ALK-5 pathway","volume":"27","author":"Haas","year":"2009","journal-title":"Growth Factors"},{"key":"10.1016\/j.canlet.2026.218437_bib248","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1470-2045(04)01431-7","article-title":"Tumour-cell migration, invasion, and metastasis: navigation by neurotransmitters","volume":"5","author":"Entschladen","year":"2004","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib249","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1158\/2159-8290.CD-20-0775","article-title":"Netrin G1 promotes pancreatic tumorigenesis through cancer-associated fibroblast\u2013driven nutritional support and immunosuppression","volume":"11","author":"Francescone","year":"2021","journal-title":"Cancer Discov."},{"key":"10.1016\/j.canlet.2026.218437_bib250","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2014.557","article-title":"Stromal SLIT2 impacts on pancreatic cancer-associated neural remodeling","volume":"6","author":"Secq","year":"2015","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218437_bib251","doi-asserted-by":"crossref","first-page":"eadi0178","DOI":"10.1126\/scitranslmed.adi0178","article-title":"Extracellular vesicle\u2013packaged PIAT from cancer-associated fibroblasts drives neural remodeling by mediating m5C modification in pancreatic cancer mouse models","volume":"16","author":"Zheng","year":"2024","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib252","doi-asserted-by":"crossref","first-page":"5639","DOI":"10.1158\/0008-5472.CAN-17-0546","article-title":"\u03b2-Adrenergic signaling in mice housed at standard temperatures suppresses an effector phenotype in CD8+ T cells and undermines checkpoint inhibitor therapy","volume":"77","author":"Bucsek","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib253","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/0008-5472.CAN-12-0764","article-title":"Endoneurial macrophages induce perineural invasion of pancreatic cancer cells by secretion of GDNF and activation of RET tyrosine kinase receptor","volume":"72","author":"Cavel","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib254","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1016\/j.ccell.2025.09.003","article-title":"Sensory neurons drive pancreatic cancer progression through glutamatergic neuron-cancer pseudo-synapses","volume":"43","author":"Ren","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib255","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41586-025-08735-3","article-title":"Characterization of single neurons reprogrammed by pancreatic cancer","volume":"640","author":"Thiel","year":"2025","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib256","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nature12477","article-title":"Signatures of mutational processes in human cancer","volume":"500","author":"Alexandrov","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib257","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1038\/ng.3441","article-title":"Clock-like mutational processes in human somatic cells","volume":"47","author":"Alexandrov","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.canlet.2026.218437_bib258","doi-asserted-by":"crossref","DOI":"10.1016\/j.dnarep.2020.102905","article-title":"Molecular origins of APOBEC-associated mutations in cancer","volume":"94","author":"Petljak","year":"2020","journal-title":"DNA Repair"},{"key":"10.1016\/j.canlet.2026.218437_bib259","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/s41389-022-00411-9","article-title":"Aberrant APOBEC3C expression induces characteristic genomic instability in pancreatic ductal adenocarcinoma","volume":"11","author":"Qian","year":"2022","journal-title":"Oncogenesis"},{"key":"10.1016\/j.canlet.2026.218437_bib260","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1038\/s43018-024-00742-z","article-title":"Cytidine deaminases APOBEC3C and APOBEC3D promote DNA replication stress resistance in pancreatic cancer cells","volume":"5","author":"Ubhi","year":"2024","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib261","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/s43018-021-00268-8","article-title":"APOBEC3A drives deaminase domain-independent chromosomal instability to promote pancreatic cancer metastasis","volume":"2","author":"W\u00f6rmann","year":"2021","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib262","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJMoa1903387","article-title":"Maintenance olaparib for germline BRCA-mutated metastatic pancreatic cancer","volume":"381","author":"Golan","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib263","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.606820","article-title":"Interpreting sequence variation in PDAC-predisposing genes using a multi-tier annotation approach performed at the gene, patient, and cohort level","volume":"11","author":"Zimmermann","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib264","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1038\/bjc.2014.418","article-title":"Overall survival and clinical characteristics of pancreatic cancer in BRCA mutation carriers","volume":"111","author":"Golan","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib265","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1001\/jamaoncol.2016.3916","article-title":"Association of distinct mutational signatures with correlates of increased immune activity in pancreatic ductal adenocarcinoma","volume":"3","author":"Connor","year":"2017","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib266","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1158\/1078-0432.CCR-17-3099","article-title":"Evaluating mismatch repair deficiency in pancreatic adenocarcinoma: challenges and recommendations","volume":"24","author":"Hu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib267","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16112111","article-title":"Mutations in mismatch repair genes and microsatellite instability status in pancreatic cancer","volume":"16","author":"Emelyanova","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canlet.2026.218437_bib268","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2021.39.3_suppl.415","article-title":"Investigate the efficacy of immunotherapy for treatment of pancreatic adenocarcinoma (PDAC) with mismatch repair deficiency (dMMR)","volume":"39","author":"Noor","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib269","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ejca.2023.04.012","article-title":"Efficacy of immune checkpoint inhibitors in microsatellite unstable\/mismatch repair-deficient advanced pancreatic adenocarcinoma: an AGEO european cohort","volume":"188","author":"Ta\u00efeb","year":"2023","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib270","series-title":"Efficacy of Immune Checkpoint Inhibition and Cytotoxic Chemotherapy in Mismatch Repair-Deficient and Microsatellite Instability-High Pancreatic Cancer: Mayo Clinic Experience","author":"Coston","year":"2023"},{"key":"10.1016\/j.canlet.2026.218437_bib271","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.749490","article-title":"DNA damage repair deficiency in pancreatic ductal adenocarcinoma: preclinical models and clinical perspectives","volume":"9","author":"Stoof","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.canlet.2026.218437_bib272","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1091\/mbc.E18-07-0439","article-title":"Selective defects in gene expression control genome instability in yeast splicing mutants","volume":"30","author":"Tam","year":"2019","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib273","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1053\/j.gastro.2020.08.018","article-title":"The long noncoding RNA CCAT2 induces chromosomal instability through BOP1-AURKB signaling","volume":"159","author":"Chen","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib274","doi-asserted-by":"crossref","DOI":"10.15252\/embj.2019104133","article-title":"BGL3 lncRNA mediates retention of the BRCA1\/BARD1 complex at DNA damage sites","volume":"39","author":"Hu","year":"2020","journal-title":"EMBO J."},{"key":"10.1016\/j.canlet.2026.218437_bib275","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12864-023-09209-4","article-title":"Multi-level integrative analysis of the roles of lncRNAs and differential mRNAs in the progression of chronic pancreatitis to pancreatic ductal adenocarcinoma","volume":"24","author":"Zhao","year":"2023","journal-title":"BMC Genom."},{"key":"10.1016\/j.canlet.2026.218437_bib276","article-title":"A novel genomic instability-derived lncRNA signature to predict prognosis and immune characteristics of pancreatic ductal adenocarcinoma","volume":"13","author":"Yang","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.canlet.2026.218437_bib277","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3390\/cancers9050042","article-title":"KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 mutations in pancreatic cancer","volume":"9","author":"Cicenas","year":"2017","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218437_bib278","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.256.5058.827","article-title":"Oncogenic forms of p53 inhibit p53-regulated gene expression","volume":"256","author":"Kern","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.canlet.2026.218437_bib279","first-page":"1534","article-title":"Pancreatic adenocarcinomas frequently show p53 gene mutations","volume":"142","author":"Scarpa","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.canlet.2026.218437_bib280","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ccell.2017.07.007","article-title":"Integrated genomic characterization of pancreatic ductal adenocarcinoma","volume":"32","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib281","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1073\/pnas.0908428107","article-title":"Mutant p53 drives metastasis and overcomes growth arrest\/senescence in pancreatic cancer","volume":"107","author":"Morton","year":"2010","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.canlet.2026.218437_bib282","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.bbamcr.2014.10.003","article-title":"Mutant p53 stimulates chemoresistance of pancreatic adenocarcinoma cells to gemcitabine","volume":"1853","author":"Fiorini","year":"2015","journal-title":"Biochim. Biophys. Acta, Mol. Cell Res."},{"key":"10.1016\/j.canlet.2026.218437_bib283","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1053\/j.gastro.2016.03.010","article-title":"Loss of P53 function activates JAK2-STAT3 signaling to promote pancreatic tumor growth, stroma modification, and gemcitabine resistance in mice and is associated with patient survival","volume":"151","author":"W\u00f6rmann","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib284","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/nm0302-282","article-title":"Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound","volume":"8","author":"Bykov","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib285","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.tips.2010.11.004","article-title":"Reactivation of p53: from peptides to small molecules","volume":"32","author":"Brown","year":"2011","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib286","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nrc.2017.109","article-title":"Targeting mutant p53 for efficient cancer therapy","volume":"18","author":"Bykov","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib287","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s10637-014-0090-9","article-title":"PRIMA-1, a mutant p53 reactivator, induces apoptosis and enhances chemotherapeutic cytotoxicity in pancreatic cancer cell lines","volume":"32","author":"Izetti","year":"2014","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2026.218437_bib288","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s10637-023-01380-5","article-title":"The p53 reactivator PRIMA-1(MET) synergises with 5-fluorouracil to induce apoptosis in pancreatic cancer cells","volume":"41","author":"Mohammed","year":"2023","journal-title":"Invest. N. Drugs"},{"key":"10.1016\/j.canlet.2026.218437_bib289","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","article-title":"KRAS: feeding pancreatic cancer proliferation","volume":"39","author":"Bryant","year":"2014","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.canlet.2026.218437_bib290","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1053\/gast.2002.37075","article-title":"Stat3 and NF-\u03baB activation prevents apoptosis in pancreatic carcinogenesis","volume":"123","author":"Greten","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib291","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i2.20","article-title":"Signaling pathways in pancreatic cancer","volume":"21","author":"Preis","year":"2011","journal-title":"Crit. Rev. Eukaryot. Gene Expr."},{"key":"10.1016\/j.canlet.2026.218437_bib292","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1038\/nrc.2017.53","article-title":"Targeting autophagy in cancer","volume":"17","author":"Levy","year":"2017","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib293","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1101\/gad.2016111","article-title":"Pancreatic cancers require autophagy for tumor growth","volume":"25","author":"Yang","year":"2011","journal-title":"Genes Dev."},{"key":"10.1016\/j.canlet.2026.218437_bib294","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3892\/or.2014.3298","article-title":"Upregulation of autophagy by hypoxia-inducible factor-1\u03b1 promotes EMT and metastatic ability of CD133+ pancreatic cancer stem-like cells during intermittent hypoxia","volume":"32","author":"Zhu","year":"2014","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.canlet.2026.218437_bib295","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/nature12865","article-title":"p53 status determines the role of autophagy in pancreatic tumour development","volume":"504","author":"Rosenfeldt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib296","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1053\/j.gastro.2018.09.053","article-title":"Levels of the autophagy-related 5 protein affect progression and metastasis of pancreatic tumors in mice","volume":"156","author":"G\u00f6rg\u00fcl\u00fc","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.canlet.2026.218437_bib297","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1091\/mbc.e10-06-0500","article-title":"Autophagy facilitates glycolysis during ras-mediated oncogenic transformation","volume":"22","author":"Lock","year":"2011","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib298","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2016.202","article-title":"The pancreatitis-associated protein VMP1, a key regulator of inducible autophagy, promotes Kras(G12D)-mediated pancreatic cancer initiation","volume":"7","author":"Loncle","year":"2016","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.canlet.2026.218437_bib299","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/cdd.2009.149","article-title":"The receptor for advanced glycation end products (RAGE) sustains autophagy and limits apoptosis, promoting pancreatic tumor cell survival","volume":"17","author":"Kang","year":"2010","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.canlet.2026.218437_bib300","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1016\/j.ejca.2014.01.011","article-title":"Autophagy is needed for the growth of pancreatic adenocarcinoma and has a cytoprotective effect against anticancer drugs","volume":"50","author":"Hashimoto","year":"2014","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib301","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s12943-015-0449-3","article-title":"Blockade of autophagy reduces pancreatic cancer stem cell activity and potentiates the tumoricidal effect of gemcitabine","volume":"14","author":"Yang","year":"2015","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib302","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.canlet.2018.08.010","article-title":"USP9X inhibition improves gemcitabine sensitivity in pancreatic cancer by inhibiting autophagy","volume":"436","author":"Ma","year":"2018","journal-title":"Cancer Lett."},{"key":"10.1016\/j.canlet.2026.218437_bib303","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41591-019-0368-8","article-title":"Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer","volume":"25","author":"Bryant","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib304","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/s41591-019-0367-9","article-title":"Protective autophagy elicited by RAF\u2192MEK\u2192ERK inhibition suggests a treatment strategy for RAS-driven cancers","volume":"25","author":"Kinsey","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib305","article-title":"Overcoming adaptive resistance to KRAS and MEK inhibitors by Co-targeting mTORC1\/2 complexes in pancreatic cancer","volume":"1","author":"Brown","year":"2020","journal-title":"Cell Rep. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib306","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s42255-020-0172-2","article-title":"We need to talk about the Warburg effect","volume":"2","author":"DeBerardinis","year":"2020","journal-title":"Nat. Metab."},{"key":"10.1016\/j.canlet.2026.218437_bib307","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.cell.2012.01.058","article-title":"Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism","volume":"149","author":"Ying","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib308","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1002\/mco2.37","article-title":"The biological role of metabolic reprogramming in pancreatic cancer","volume":"1","author":"Suzuki","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.canlet.2026.218437_bib309","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3390\/cancers13040601","article-title":"Stellate cells aid growth-permissive metabolic reprogramming and promote gemcitabine chemoresistance in pancreatic cancer","volume":"13","author":"Amrutkar","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.canlet.2026.218437_bib310","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nature12040","article-title":"Glutamine supports pancreatic cancer growth through a KRAS-regulated metabolic pathway","volume":"496","author":"Son","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.canlet.2026.218437_bib311","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.bbcan.2018.04.011","article-title":"The plasticity of pancreatic cancer metabolism in tumor progression and therapeutic resistance","volume":"1870","author":"Biancur","year":"2018","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.canlet.2026.218437_bib312","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/s12943-024-01977-1","article-title":"Crosstalk between metabolism and cell death in tumorigenesis","volume":"23","author":"Yang","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib313","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1158\/1541-7786.MCR-22-0554","article-title":"MYC\/Glutamine dependency is a therapeutic vulnerability in pancreatic cancer with deoxycytidine kinase inactivation-induced gemcitabine resistance","volume":"21","author":"Dash","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.canlet.2026.218437_bib314","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202509","article-title":"SLC38A5 modulates ferroptosis to overcome gemcitabine resistance in pancreatic cancer","volume":"12","author":"Kim","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.canlet.2026.218437_bib315","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.3724\/abbs.2023029","article-title":"Glutamine deprivation induces ferroptosis in pancreatic cancer cells","volume":"55","author":"Xiao","year":"2023","journal-title":"Acta Biochim. Biophys. Sin."},{"key":"10.1016\/j.canlet.2026.218437_bib316","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1038\/s12276-024-01231-0","article-title":"Glutamine-mediated epigenetic regulation of cFLIP underlies resistance to TRAIL in pancreatic cancer","volume":"56","author":"Kim","year":"2024","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.canlet.2026.218437_bib317","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fmolb.2020.00071","article-title":"New insights into the role of phenotypic plasticity and EMT in driving cancer progression","volume":"7","author":"Bhatia","year":"2020","journal-title":"Front. Mol. Biosci."},{"key":"10.1016\/j.canlet.2026.218437_bib318","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.7150\/jca.38616","article-title":"Molecular mechanism of pancreatic stellate cells activation in chronic pancreatitis and pancreatic cancer","volume":"11","author":"Jin","year":"2020","journal-title":"J. Cancer"},{"key":"10.1016\/j.canlet.2026.218437_bib319","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S1535-6108(03)00140-5","article-title":"Notch mediates TGF\u03b1-induced changes in epithelial differentiation during pancreatic tumorigenesis","volume":"3","author":"Miyamoto","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.canlet.2026.218437_bib320","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2025.102479","article-title":"Understanding the heterogeneity of pancreatic ductal adenocarcinoma","volume":"60","author":"Iovanna","year":"2025","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.canlet.2026.218437_bib321","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/s41586-025-08721-9","article-title":"MYC ecDNA promotes intratumour heterogeneity and plasticity in PDAC","volume":"640","author":"Fiorini","year":"2025","journal-title":"Nature"},{"issue":"4","key":"10.1016\/j.canlet.2026.218437_bib322","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/cgt.2013.9","article-title":"Transferrin receptor targeting nanomedicine delivering wild-type p53 gene sensitizes pancreatic cancer to gemcitabine therapy","volume":"20","author":"Camp","year":"2013","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.canlet.2026.218437_bib323","article-title":"Phase II Study of Combined Targeted p53 Gene Therapy (SGT-53) Plus Gemcitabine\/Nab-Paclitaxel for Treatment of Metastatic Pancreatic","year":"2014","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.canlet.2026.218437_bib324","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/MPA.0b013e3181f95104","article-title":"Elevated transcript levels from the MDM2 P1 promoter and low p53 transcript levels are associated with poor prognosis in human pancreatic ductal adenocarcinoma","volume":"40","author":"Grochola","year":"2011","journal-title":"Pancreas"},{"key":"10.1016\/j.canlet.2026.218437_bib325","doi-asserted-by":"crossref","first-page":"156186","DOI":"10.1016\/j.prp.2025.156186","article-title":"Pracinostat inhibits the nefarious biological behavior of pancreatic cancer by targeting the miR-381-3p\/MDM2 axis to activate the p53 signaling pathway","volume":"274","author":"Cun","year":"2025","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.canlet.2026.218437_bib326","year":"2022"}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383526002004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T06:16:09Z","timestamp":1782108969000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383526002004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":326,"alternative-id":["S0304383526002004"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218437","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The hallmarks of pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canlet.2026.218437","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"218437"}}